Menu
Recruiting NCT04120688

3D Autotransplantation of Teeth

No phase Interventional Tooth Loss

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: 3D generated tooth replica.
Who it may be relevant to
Registry conditions: Tooth Loss. Basic parameters: 9 years — 23 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Finland
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Overview

The study aims to clarify the usefulness of 3D-printed replicas in association with autotransplantation of teeth in children and young adults.

Interventions

  • Device 3D generated tooth replica
    3D generated tooth replicas are compared to conventional procedure

Primary outcome measures

  • Number of patients with healthy transplanted teeth as assessed by clinical examination at one year. [Time frame: One year postoperatively]
  • Number of patients with healthy transplanted teeth as assessed by radiological examination at one year. [Time frame: One year postoperatively]

Eligibility criteria

Inclusion criteria

  • Need for tooth transplantation
  • Open apex tooth available for transplantation

Exclusion criteria

  • Facial syndrome
  • Chronic facial pain
  • Allergy to replica material

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
Randomized
Model
Parallel assignment
Masking
Single blind
Primary purpose
Treatment

Study locations

Finland · 1 center
  • Turku University Hospital — Turku

Identifiers

NCT: NCT04120688 · T282/2019

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗